Up Next
-
1m 11sPart 4 | Session 2 Gary Mintz
-
24sPart 4 | Session 3 Rajesh Kharbanda
-
27sPart 5 | Session 1 Michael Joner
-
1m 47sPart 5 | Session 2 Gary Mintz
-
24sPart 5 | Session 3 Rajesh Kharbanda
-
27sPart 6 | Session 1 Michael Joner
-
1m 5sPart 6 | Session 2 Gary Mintz
-
31sPart 6 | Session 3 Rajesh Kharbanda
-
27sPart 7 | Session 1 Michael Joner
-
1m 7sPart 7 | Session 2 Gary Mintz
-
30sPart 7 | Session 3 Rajesh Kharbanda
-
28sPart 8 | Session 1 Michael Joner
-
51sPart 8 | Session 2 Gary Mintz
-
32sPart 8 | Session 3 Rajesh Kharbanda
-
26sPart 1 | Session 1 Michael Joner
-
48sPart 1 | Session 2 Gary Mintz
-
41sPart 1 | Session 3 Rajesh Kharbanda
-
25sPart 2 | Session 1 Michael Joner
-
37sPart 2 | Session 2 Gary Mintz
-
51sPart 2 | Session 3 Rajesh Kharbanda
-
22sPart 3 | Session 1 Michael Joner
-
48sPart 3 | Session 2 Gary Mintz
-
37sPart 3 | Session 3 Rajesh Kharbanda
Overview
A short series of 60-second insight videos on Optical Coherence Tomography (OCT). Hear the expert views in under one minute!
More from this programme
Part 1
Do you think the role of OCT has diminished following the withdrawal of BVS?
Part 2
What tips would you give for administering contrast?
Part 3
What is the most important trial to support the use of OCT?
Part 4
What disadvantages do you think OCT offers over other imaging modalities?
Part 5
What cases would you use OCT in?
Part 6
What cases would you not use OCT in?
Part 7
What advantages do you think OCT offers over other imaging modalities?
Part 8
Should we trust dimensions from OCT or IVUS, and why?
Faculty Biographies
Michael Joner
Head of the Preclinical Research
Prof Michael Joner is DZHK Professor for Early Clinical Trials at the German Heart Centre in Munich, Germany. His main research focus is on findings novel diagnostic or therapeutic pathways to target atherosclerosis.
Prof Joner completed his medical training at the University of Wuerzburg in Würzburg, Germany. During his course, he went on to complete a 2-year fellowship in cardiovascular pathology under the lead of Prof Virmani in Washington DC.